Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Continuous glucose monitoring results in lower HbA1c in Malaysian women with insulin-treated gestational diabetes: a randomized controlled trial.

Paramasivam SS, Chinna K, Singh AKK, Ratnasingam J, Ibrahim L, Lim LL, Tan ATB, Chan SP, Tan PC, Omar SZ, Bilous RW, Vethakkan SR.

Diabet Med. 2018 Aug;35(8):1118-1129. doi: 10.1111/dme.13649. Epub 2018 May 23.

PMID:
29663517
2.

Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with Diabetes.

Scott EM, Bilous RW, Kautzky-Willer A.

Diabetes Technol Ther. 2018 Mar;20(3):180-188. doi: 10.1089/dia.2017.0386. Epub 2018 Feb 22.

3.

Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker.

Pontillo C, Zhang ZY, Schanstra JP, Jacobs L, Zürbig P, Thijs L, Ramírez-Torres A, Heerspink HJL, Lindhardt M, Klein R, Orchard T, Porta M, Bilous RW, Charturvedi N, Rossing P, Vlahou A, Schepers E, Glorieux G, Mullen W, Delles C, Verhamme P, Vanholder R, Staessen JA, Mischak H, Jankowski J.

Kidney Int Rep. 2017 Nov;2(6):1066-1075. doi: 10.1016/j.ekir.2017.06.004.

4.

A cost-effectiveness comparison of the NICE 2015 and WHO 2013 diagnostic criteria for women with gestational diabetes with and without risk factors.

Jacklin PB, Maresh MJ, Patterson CC, Stanley KP, Dornhorst A, Burman-Roy S, Bilous RW.

BMJ Open. 2017 Aug 11;7(8):e016621. doi: 10.1136/bmjopen-2017-016621.

5.

Translating HbA1c measurements into estimated average glucose values in pregnant women with diabetes.

Law GR, Gilthorpe MS, Secher AL, Temple R, Bilous R, Mathiesen ER, Murphy HR, Scott EM.

Diabetologia. 2017 Apr;60(4):618-624. doi: 10.1007/s00125-017-4205-7. Epub 2017 Jan 19.

6.

Determining the Optimal Protocol for Measuring an Albuminuria Class Transition in Clinical Trials in Diabetic Kidney Disease.

Kröpelin TF, de Zeeuw D, Remuzzi G, Bilous R, Parving HH, Heerspink HJ.

J Am Soc Nephrol. 2016 Nov;27(11):3405-3412. Epub 2016 Apr 7.

7.

Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study.

Lindhardt M, Persson F, Zürbig P, Stalmach A, Mischak H, de Zeeuw D, Lambers Heerspink H, Klein R, Orchard T, Porta M, Fuller J, Bilous R, Chaturvedi N, Parving HH, Rossing P.

Nephrol Dial Transplant. 2017 Nov 1;32(11):1866-1873. doi: 10.1093/ndt/gfw292.

PMID:
27507891
8.

The SSTARS (STeroids and Stents Against Re-Stenosis) Trial: Different stent alloys and the use of peri-procedural oral corticosteroids to prevent in-segment restenosis after percutaneous coronary intervention.

Adam Z, Turley A, Mason JM, Kasim AS, Newby D, Mills N, Padfield G, Thompson L, Morley R, Hall JA, Wright RA, Muir DF, Sutton AG, Swanson N, Carter J, Bilous R, Jones S, de Belder MA.

Int J Cardiol. 2016 Aug 1;216:1-8. doi: 10.1016/j.ijcard.2016.04.105. Epub 2016 Apr 29.

PMID:
27135149
9.

CKD and Diabetes: What Can We Learn From Their Similarities and Differences?

Levey AS, Bilous R, Shlipak MG.

Am J Kidney Dis. 2016 Mar;67(3):360-3. doi: 10.1053/j.ajkd.2015.12.003. No abstract available.

PMID:
26916373
10.

Reversible weakness and encephalopathy while on long-term valproate treatment due to carnitine deficiency.

Al-sharefi A, Bilous R.

BMJ Case Rep. 2015 Sep 2;2015. pii: bcr2015210727. doi: 10.1136/bcr-2015-210727.

11.

Laboratory Assessment of Diabetic Kidney Disease.

Narva AS, Bilous RW.

Diabetes Spectr. 2015 Aug;28(3):162-6. doi: 10.2337/diaspect.28.3.162.

12.

Diagnosis of gestational diabetes, defining the net, refining the catch.

Bilous R.

Diabetologia. 2015 Sep;58(9):1965-8. doi: 10.1007/s00125-015-3695-4. Epub 2015 Jul 15.

PMID:
26173673
13.

Risk and recurrence of serious adverse outcomes in the first and second pregnancies of women with preexisting diabetes.

Tennant PW, Bilous RW, Prathapan S, Bell R.

Diabetes Care. 2015 Apr;38(4):610-9. doi: 10.2337/dc14-1888. Epub 2015 Jan 8.

14.

Diabetic kidney disease: a report from an ADA Consensus Conference.

Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME.

Am J Kidney Dis. 2014 Oct;64(4):510-33. doi: 10.1053/j.ajkd.2014.08.001.

PMID:
25257325
15.

Diabetic kidney disease: a report from an ADA Consensus Conference.

Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME.

Diabetes Care. 2014 Oct;37(10):2864-83. doi: 10.2337/dc14-1296.

16.

Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed? Reply to Lewis G and Maxwell AP [letter].

Tennant PW, Glinianaia SV, Bilous RW, Rankin J, Bell R.

Diabetologia. 2014 May;57(5):1084-5. doi: 10.1007/s00125-014-3191-2. Epub 2014 Feb 15. No abstract available.

PMID:
24531223
17.

Glycemic control and mortality in diabetic patients undergoing hemodialysis: much more to learn.

Bilous RW.

Am J Kidney Dis. 2014 Jan;63(1):10-2. doi: 10.1053/j.ajkd.2013.10.005. No abstract available.

PMID:
24360224
18.

Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study.

Tennant PW, Glinianaia SV, Bilous RW, Rankin J, Bell R.

Diabetologia. 2014 Feb;57(2):285-94. doi: 10.1007/s00125-013-3108-5. Epub 2013 Nov 29.

19.

Universal screening to identify gestational diabetes: a multi-centre study in the North of England.

Hayes L, Bilous R, Bilous M, Brandon H, Crowder D, Emmerson C, Lewis-Barned N, Bell R.

Diabetes Res Clin Pract. 2013 Jun;100(3):e74-7. doi: 10.1016/j.diabres.2013.03.019. Epub 2013 Apr 2.

PMID:
23561059
20.

HbA(1c) and birthweight in women with pre-conception type 1 and type 2 diabetes: a population-based cohort study.

Glinianaia SV, Tennant PW, Bilous RW, Rankin J, Bell R.

Diabetologia. 2012 Dec;55(12):3193-203. doi: 10.1007/s00125-012-2721-z. Epub 2012 Sep 27.

PMID:
23015260
21.
22.

Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy Trial.

Evans M, Bain SC, Hogan S, Bilous RW; Collaborative Study Group participants.

Nephrol Dial Transplant. 2012 Jun;27(6):2255-63. doi: 10.1093/ndt/gfr696. Epub 2011 Dec 15.

PMID:
22172728
23.

Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme.

Sjølie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, Bilous R, Aldington S, Chaturvedi N.

Diabet Med. 2011 Mar;28(3):345-51. doi: 10.1111/j.1464-5491.2010.03210.x.

PMID:
21309844
24.

Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials.

Porta M, Hainer JW, Jansson SO, Malm A, Bilous R, Chaturvedi N, Fuller JH, Klein R, Orchard T, Parving HH, Sjølie AK; DIRECT Study Group.

Diabetologia. 2011 Jun;54(6):1298-303. doi: 10.1007/s00125-010-2040-1. Epub 2011 Jan 12.

PMID:
21225239
25.

Peroxisome proliferator-activated receptor-γ agonist rosiglitazone prevents albuminuria but not glomerulosclerosis in experimental diabetes.

Setti G, Hayward A, Dessapt C, Barone F, Buckingham R, White K, Bilous R, Hiroshi K, Gruden G, Viberti G, Gnudi L.

Am J Nephrol. 2010;32(5):393-402. doi: 10.1159/000320129. Epub 2010 Sep 3.

PMID:
20814199
26.

Prevalence and nature of anaemia in a prospective, population-based sample of people with diabetes: Teesside anaemia in diabetes (TAD) study.

Jones SC, Smith D, Nag S, Bilous MT, Winship S, Wood A, Bilous RW.

Diabet Med. 2010 Jun;27(6):655-9. doi: 10.1111/j.1464-5491.2010.02987.x.

PMID:
20546283
27.

Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials.

Bilous R, Chaturvedi N, Sjølie AK, Fuller J, Klein R, Orchard T, Porta M, Parving HH.

Ann Intern Med. 2009 Jul 7;151(1):11-20, W3-4. Epub 2009 May 18.

PMID:
19451554
28.

Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis.

Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG.

Diabetologia. 2009 Apr;52(4):691-7. doi: 10.1007/s00125-009-1268-0. Epub 2009 Feb 7.

PMID:
19198800
29.

Cigarette smoking during pregnancy is associated with alterations in maternal and fetal thyroid function.

Shields B, Hill A, Bilous M, Knight B, Hattersley AT, Bilous RW, Vaidya B.

J Clin Endocrinol Metab. 2009 Feb;94(2):570-4. doi: 10.1210/jc.2008-0380. Epub 2008 Nov 18.

PMID:
19017761
30.

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.

Sjølie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, Bilous R, Chaturvedi N; DIRECT Programme Study Group.

Lancet. 2008 Oct 18;372(9647):1385-93. doi: 10.1016/S0140-6736(08)61411-7. Epub 2008 Sep 25.

31.

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.

Chaturvedi N, Porta M, Klein R, Orchard T, Fuller J, Parving HH, Bilous R, Sjølie AK; DIRECT Programme Study Group.

Lancet. 2008 Oct 18;372(9647):1394-402. doi: 10.1016/S0140-6736(08)61412-9. Epub 2008 Sep 25.

PMID:
18823656
32.

Microvascular disease: what does the UKPDS tell us about diabetic nephropathy?

Bilous R.

Diabet Med. 2008 Aug;25 Suppl 2:25-9. doi: 10.1111/j.1464-5491.2008.02496.x.

PMID:
18717975
33.

Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney.

Bilous R.

Prim Care Diabetes. 2008 Dec;2(4):201-2. doi: 10.1016/j.pcd.2008.06.002. Epub 2008 Aug 28. No abstract available.

PMID:
18760685
34.

Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice.

Ku CH, White KE, Dei Cas A, Hayward A, Webster Z, Bilous R, Marshall S, Viberti G, Gnudi L.

Diabetes. 2008 Oct;57(10):2824-33. doi: 10.2337/db08-0647. Epub 2008 Jul 22.

35.

Prevalence of atubular glomeruli in type 2 diabetic patients with nephropathy.

White KE, Marshall SM, Bilous RW.

Nephrol Dial Transplant. 2008 Nov;23(11):3539-45. doi: 10.1093/ndt/gfn351. Epub 2008 Jun 16.

PMID:
18558622
36.

Rosiglitazone and myocardial infarction: cause for concern or misleading meta-analysis?

Bilous RW.

Diabet Med. 2007 Sep;24(9):931-3. No abstract available.

PMID:
17725705
37.

Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus.

Chaturvedi N, Bilous R, Sjolie AK, Klein R; DIRECT Programme Steering Committee.

Contemp Clin Trials. 2007 Nov;28(6):780. Epub 2007 Jun 26. No abstract available.

PMID:
17643353
38.

Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia.

Davis B, Dei Cas A, Long DA, White KE, Hayward A, Ku CH, Woolf AS, Bilous R, Viberti G, Gnudi L.

J Am Soc Nephrol. 2007 Aug;18(8):2320-9. Epub 2007 Jul 11.

39.

The management of proteinuria in diabetes.

Bilous R.

Clin Med (Lond). 2007 Apr;7(2):116-7. Review. No abstract available.

40.

Misleading meta-analysis: a need to look beyond the headlines.

Chaturvedi N, Bilous R, Hardy R, Remuzzi G, Ruggenenti P, Viberti GC.

Diabet Med. 2007 Jun;24(6):587-91. Epub 2007 May 8. No abstract available.

PMID:
17490423
41.

Are glomerular volume differences between type 1 and type 2 diabetic patients pathologically significant?

White KE, Marshall SM, Bilous RW.

Diabetologia. 2007 May;50(5):906-12. Epub 2007 Feb 27. Review.

PMID:
17333103
42.

Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study.

Ritz E, Laville M, Bilous RW, O'Donoghue D, Scherhag A, Burger U, de Alvaro F; Anemia Correction in Diabetes Study Investigators.

Am J Kidney Dis. 2007 Feb;49(2):194-207. Erratum in: Am J Kidney Dis. 2007 Apr;49(4):562.

PMID:
17261422
43.

DREAM and ADOPT: rosiglitazone does what it says on the packet.

Bilous R.

Diabet Med. 2007 Feb;24(2):107-9. No abstract available. Erratum in: Diabet Med. 2007 Apr;24(4):449.

PMID:
17257270
45.

Detection of thyroid dysfunction in early pregnancy: Universal screening or targeted high-risk case finding?

Vaidya B, Anthony S, Bilous M, Shields B, Drury J, Hutchison S, Bilous R.

J Clin Endocrinol Metab. 2007 Jan;92(1):203-7. Epub 2006 Oct 10.

PMID:
17032713
46.

The prevalence and management of cardiorenal risk factors in patients with diabetic nephropathy.

Bilous R.

Nat Clin Pract Endocrinol Metab. 2006 Oct;2(10):548-9. No abstract available.

PMID:
17024152
47.

Time to move from serum creatinine to eGFR.

New JP, O'Donoghue DJ, Middleton RJ, Rudenski A, Dasgupta I, Bilous RW, Marshall SM.

Diabet Med. 2006 Oct;23(10):1047-9. No abstract available.

PMID:
16978366
48.

Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes.

Ashwell SG, Amiel SA, Bilous RW, Dashora U, Heller SR, Hepburn DA, Shutler SD, Stephens JW, Home PD.

Diabet Med. 2006 Mar;23(3):285-92.

PMID:
16492212
49.

Will ASCOT change the form of anti-hypertensive therapy?

Bilous R.

Diabet Med. 2006 Jan;23(1):13-4. Review. No abstract available.

PMID:
16409559
50.

The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: baseline characteristics.

Sjølie AK, Porta M, Parving HH, Bilous R, Klein R; DIRECT Programme Study Group.

J Renin Angiotensin Aldosterone Syst. 2005 Mar;6(1):25-32.

PMID:
16088848

Supplemental Content

Loading ...
Support Center